Skip to main content
. 2022 Jun 30;25(8):104702. doi: 10.1016/j.isci.2022.104702

Figure 4.

Figure 4

Kaplan-Meier curve of model-predicted duration of response in (A) nab-paclitaxel monotherapy and (B) combination treatment of nab-paclitaxel and atezolizumab

Duration of response is defined as the time from the achievement of a response to progression. The median durations of the response with 95% bootstrap confidence intervals are 5.6 (5.6–7.5) and 7.5 (5.6–9.3) months, respectively.